Pepsi Vs Coke Stock: Which Is Best?
Coca-Cola (NYSE:KO) and PepsiCo (NYSE:PEP) are two of the largest…
Sell
42
DBD Quote, Financials, Valuation and Earnings
Last price:
$43.85
Seasonality move
:
22.4%
Day range:
$42.57 - $43.78
52-week range:
$30.37 - $51.81
Dividend yield:
0%
P/E ratio:
356.62x
P/S ratio:
0.44x
P/B ratio:
1.77x
Volume:
106K
Avg. volume:
136.5K
1-year change:
25.23%
Market cap:
$1.6B
Revenue:
$3.8B
EPS (TTM):
-$0.44
Analysts' Opinion
-
Consensus RatingDiebold Nixdorf has received a consensus rating of Buy. The company's average rating is a Buy based on 2 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $70.00, Diebold Nixdorf has an estimated upside of 59.89% from its current price of $43.78.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $60.00 representing 100% downside risk from its current price of $43.78.
Fair Value
-
According to the consensus of 2 analysts, Diebold Nixdorf has 59.89% upside to fair value with a price target of $70.00 per share.
DBD vs. S&P 500
-
Over the past 5 trading days, Diebold Nixdorf has underperformed the S&P 500 by -0.4% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Diebold Nixdorf does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Diebold Nixdorf has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Diebold Nixdorf reported revenues of $988.9M.
Earnings Growth
-
Diebold Nixdorf earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Diebold Nixdorf reported earnings per share of $0.15.
Enterprise value:
2.3B
EV / Invested capital:
1.22x
Price / LTM sales:
0.44x
EV / EBIT:
11.21x
EV / Revenue:
0.61x
PEG ratio (5yr expected):
-0.29x
EV / Free cash flow:
20.87x
Price / Operating cash flow:
15.14x
Enterprise value / EBITDA:
6.78x
Gross Profit (TTM):
$920M
Return On Assets:
-0.43%
Net Income Margin (TTM):
-0.44%
Return On Equity:
-1.61%
Return On Invested Capital:
-0.78%
Operating Margin:
4.3%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $3.5B | -- | $3.8B | -- | $988.9M | |
| Gross Profit | $757.3M | -- | $920M | -- | $231.6M | |
| Operating Income | -$105M | -- | $182.8M | -- | $42.5M | |
| EBITDA | -$113.4M | -- | $334.9M | -- | $79.4M | |
| Diluted EPS | -$7.37 | -$11.03 | -$0.44 | $0.72 | $0.15 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.9B | $1.9B | $1.8B | $2.2B | $1.7B | |
| Total Assets | $3.7B | $3.5B | $3.1B | $4.2B | $3.5B | |
| Current Liabilities | $1.6B | $1.7B | $1.6B | $1.4B | $1.3B | |
| Total Liabilities | $4.5B | $4.3B | $4.4B | $3.1B | $2.6B | |
| Total Equity | -$812.5M | -$837M | -$1.4B | $1.1B | $938.2M | |
| Total Debt | $2.3B | $2.3B | $2.6B | $1.3B | $927.5M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$387.9M | -- | $149.2M | -- | $196.2M | |
| Cash From Investing | -$23.8M | -- | -$45.5M | -- | -$17.3M | |
| Cash From Financing | $349.8M | -- | -$366.5M | -- | -$192M | |
| Free Cash Flow | -$441M | -- | $108.8M | -- | $186.2M | |
DBD
Sector
Market Cap
$1.6B
$91.6M
Price % of 52-Week High
84.5%
60%
Dividend Yield
0%
0%
Shareholder Yield
--
0.82%
1-Year Price Total Return
25.23%
-15.91%
Beta (5-Year)
--
0.910
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$42.94
200-day SMA
Buy
Level
$43.00
Bollinger Bands (100)
Sell
Level
42.15 - 46.65
Chaikin Money Flow
Buy
Level
3.9M
20-day SMA
Sell
Level
$43.94
Relative Strength Index (RSI14)
Buy
Level
51.28
ADX Line
Buy
Level
6.92
Williams %R
Neutral
Level
-48.1703
50-day SMA
Buy
Level
$43.57
MACD (12, 26)
Sell
Level
-0.37
25-day Aroon Oscillator
Buy
Level
4
On Balance Volume
Neutral
Level
7.7M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.7553)
Sell
CA Score
(Annual)
Level (-2.3518)
Buy
Beneish M-Score
(Annual)
Level (-2.4352)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (19.1874)
Buy
Piotroski F Score
(Annual)
Level (8)
Sell
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Diebold Nixdorf Inc is engaged in providing software and hardware services for financial and retail industries. The customer segments of the company are Banking, which offers integrated solutions for financial institutions, and Retail, which offers solutions, software, and services that improve the checkout process for retailers. A majority of its revenue is generated from the Banking segment. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA), followed by the Americas and the Asia-Pacific region.
Stock Forecast FAQ
In the current month, DBD has received 2 Buy ratings 0 Hold ratings, and 0 Sell ratings. The DBD average analyst price target in the past 3 months is $70.00.
-
Where Will Diebold Nixdorf Stock Be In 1 Year?
According to analysts, the consensus estimate is that Diebold Nixdorf share price will rise to $70.00 per share over the next 12 months.
-
What Do Analysts Say About Diebold Nixdorf?
Analysts are divided on their view about Diebold Nixdorf share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Diebold Nixdorf is a Sell and believe this share price will drop from its current level to $60.00.
-
What Is Diebold Nixdorf's Price Target?
The price target for Diebold Nixdorf over the next 1-year time period is forecast to be $70.00 according to 2 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is DBD A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Diebold Nixdorf is a Buy. 2 of 2 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of DBD?
You can purchase shares of Diebold Nixdorf via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Diebold Nixdorf shares.
-
What Is The Diebold Nixdorf Share Price Today?
Diebold Nixdorf was last trading at $43.85 per share. This represents the most recent stock quote for Diebold Nixdorf. Yesterday, Diebold Nixdorf closed at $43.78 per share.
-
How To Buy Diebold Nixdorf Stock Online?
In order to purchase Diebold Nixdorf stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
52
RGC alert for Mar 18
Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 3.96% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is up 0.93% over the past day.
